financetom
Business
financetom
/
Business
/
22nd Century Group Stock Jumps 75% After Hour On News Of Reduced-Nicotine Push
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
22nd Century Group Stock Jumps 75% After Hour On News Of Reduced-Nicotine Push
Jul 16, 2025 9:53 PM

22nd Century Group Inc. ( XXII ) stock experienced a surge of 75.76% in after-hours trading on Wednesday.

What Happened: The stock of 22nd Century Group ( XXII ), a biotechnology company that specializes in tobacco, surged $8.05, marking a 75.76% rise in after-hours trading on Wednesday.

See Also: Johnson & Johnson Raises FY25 Forecast, Joins Rigetti Computing, Unity Software, Brighthouse Financial And Other Big Stocks Moving Higher On Wednesday – Benzinga

The company’s stock closed at $4.58 on Wednesday, denoting a 3.58% dip during regular trading hours. This sudden surge in the after-hours trading session follows the company’s announcement of expanding partnerships for its VLN-based reduced nicotine content products, according to a company statement.

Why It Matters: The surge in the stock price follows the news of 22nd Century Group ( XXII ) expanding its partnerships with multiple tobacco brands to increase the availability and awareness of its VLN-based reduced nicotine content products. This announcement was made earlier in July.

The company also recently issued a corporate update on the modified risk tobacco product renewal process for its VLN reduced nicotine content products.

Despite a challenging first quarter, with the company’s first quarter earnings per share missing estimates, 22nd Century Group ( XXII ) has been actively working on expanding its product lines and partnerships, which seems to be positively impacting its stock performance.

Price Action: XXII stock closed at $4.58 during regular trading hours on Wednesday.

Benzinga's Edge Stock Rankings indicate, negative trend across all time frames. Know how the stock fares on other parameters here.

Read Next: Will Bitcoin Hit $150K Before Retesting $100K? This Answer Narrowly Wins New Poll

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
International Paper, DS Smith Say Regulatory Waiting Period for Merger Expired
International Paper, DS Smith Say Regulatory Waiting Period for Merger Expired
Jun 25, 2024
08:30 AM EDT, 06/25/2024 (MT Newswires) -- International Paper ( IP ) and DS Smith said Tuesday that the waiting period under the Hart-Scott-Rodino Act for their proposed merger has expired. The companies in April announced their intention to merge in an all-stock deal valuing DS Smith at an enterprise value of about 7.80 billion British pounds ($9.89 billion). The...
Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation
Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation
Jun 25, 2024
08:31 AM EDT, 06/25/2024 (MT Newswires) -- Teva Pharmaceutical (TEVA) said on Tuesday it would pay $750 million to resolve all pending litigation concerning taxes payable for 2008-2020. Under the agreement with the Israel Tax Authority, the amount will be paid in installments between 2024 to 2029, the company said. The Israel-based drugmaker added that it has further agreed to...
Sei Investments Insider Sold Shares Worth $335,200, According to a Recent SEC Filing
Sei Investments Insider Sold Shares Worth $335,200, According to a Recent SEC Filing
Jun 25, 2024
08:33 AM EDT, 06/25/2024 (MT Newswires) -- William Doran, Director, on June 24, 2024, sold 5,000 shares in Sei Investments ( SEIC ) for $335,200. Following the Form 4 filing with the SEC, Doran has control over a total of 656,386 shares of the company, with 656,386 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/350894/000035089424000095/xslF345X03/wk-form4_1719312983.xml ...
Teva settles tax dispute in Israel with $750 mln payment
Teva settles tax dispute in Israel with $750 mln payment
Jun 25, 2024
June 25 (Reuters) - Teva Pharmaceutical Industries has entered into a deal with the Israel Tax Authority to resolve all pending litigation related to taxes payable for the years from 2008 to 2020, the drugmaker said on Tuesday. Under the agreement, Teva will pay $750 million in installments between 2024 and 2029. In future, if Teva pays dividends on, or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved